Price $17.11 |
Market Cap
91.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.5
|
P/B
2.34
|
P/S
1.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
1.3K
|
FCF
0.0
|
|
Op. Margin
8.40%
|
Net Margin
6.60%
|
ROE
8.80%
|
ROI
8.20%
|
|
ROA
7.40%
|
EPS Growth
37.50%
|
Current Ratio
4.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
